C. diff. Spores and More

Join us with guests Dr. David Lylerly, PhD - Co-Founder, CSO of TechLab and James H. Boone, M.S.,Director of Collaborative Studies, Senior Research Scientist at TechLab. Both guests will be discussing C.diff. (C.difficile) research,clinical assays for enteric and autoimmune diseases including inflammatory bowel diseases, CDI Guidelines. Dr. Lylerly and James H. Boone will also be discussing the symptoms and lab testing focused on a C. difficile infection.

If you have specific questions to be shared with our guests during the show - please e-mail them ahead of time to [email protected] Thank you.

Join us as guests Sue Barnes, RN, BSN, CIC, FAPIC, Independent and Board Certified Clinical Consultant in Infection Control and Prevention and APIC Fellow with Lori Strazdas, MPH - Public Health Liaison with Clorox Healthcare discuss the importance of C. difficile and how difficult of an infection it is to manage not only for patients but for the caretakers and loved ones. Before the patient leaves the hospitals, it is critical to understand the proper steps to reduce the spread of C. difficile spores in the home environment. In this episode, learn why it is important to focus on the home environment during and after a C. difficile infection and what can be done to reduce the risk of transmission and recurrence. Our guests will be discussing the types of disinfecting products that can be utilized to effectively kill C. diff. spores and how to use the products properly to accomplish this in the home environment.

Join us with co Author, Jay Papasan of The 1 Thing.

Our guest will be discussing ways to move forward, personal growth, habits and reaching goals in life.

If you have a questions for our guest, please e-mail it to [email protected] and be listening for your answer during our live broadcast!

Join us with guests Dr. David Lylerly, PhD - Co-Founder, CSO of TechLab and James H. Boone, M.S.,Director of Collaborative Studies, Senior Research Scientist at TechLab. Both guests will be discussing C.diff. (C.difficile) research,clinical assays for enteric and autoimmune diseases including inflammatory bowel diseases, CDI Guidelines. Dr. Lylerly and James H. Boone will also be discussing the symptoms and lab testing focused on a C. difficile infection.

If you have specific questions to be shared with our guests during the show - please e-mail them ahead of time to [email protected] Thank you.

Guest Host: Kevin Hersh and guests Susan Maboe Johnston, RN BS and Diana Gallagher, MS, RN, CWOCN CFCN will be discussing the risks that lead to infection in the hospital, and other healthcare

settings, including the challenges of skin decontamination in the hospital or acute care setting.

Join our Guest Host, Kevin Hersh with guests

Dr. Nam Tran (UC Davis), and Dr. Chris Newhouse (Roche) as they discuss the Role of Diagnostics In Supporting Antibiotic Stewardship Goals.

Dr. Newhouse will be introducing Antibiotic Resistance

with Dr. Tran who will be discussing Antibiotic Stewardship in Action followed with a group discussion on the role of Diagnostics in Antibiotic Stewardship.

Join us with our guests, Katie Stewart, Director of Health Care Ratings and Lauren Bailey, Communications Manager Manager at The Leapfrog Group. Katie and Lauren will be discussing the available resources that patients, families and caregivers can access for free to make informed decisions about their care.

The discussion will also introduce the Leapfrog Group and the powerful insight it offers. At least 200,000 people die from preventable medical errors every year. Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps forward in the quality and safety of American health care. Working with the nation’s best patient safety experts, The Leapfrog Group provides an opportunity for hospitals to measure the results of their efforts to improve patient care.

Join us with our guests, Katie Stewart, Director of Health Care Ratings and Lauren Bailey, Communications Manager Manager at The Leapfrog Group. Katie and Lauren will be discussing the available resources that patients, families and caregivers can access for free to make informed decisions about their care.

The discussion will also introduce the Leapfrog Group and the powerful insight it offers. At least 200,000 people die from preventable medical errors every year. Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps forward in the quality and safety of American health care. Working with the nation’s best patient safety experts, The Leapfrog Group provides an opportunity for hospitals to measure the results of their efforts to improve patient care.

Join us with our guest Dr. Cliff Yahnke, Ph.D. as we discuss the problem - Current environmental disinfection methods are applied at discrete moments in time (ie.episodically). The results of achieving a clean room are short-lived as harmful bacteria re-populate the space. The Solution - Indigo-Clean offers a solution that continuously disinfects the environment and bolsters your current infection prevention efforts. And the

Clinical / Laboratory Evidence and data on informational documents and research findings that either report directly on the effectiveness of the

Indigo-Clean technology, or support the importance of a clean environment and the ultimate goal of reducing Healthcare Acquired Infections (HAIs). Bactericidal Performance Testing of Indigo-Clean Upon Bacterial Species, Reducing SSI Through Improved Environmental Hygiene, and A Revolutionary New Way to Battle HAIs, Shining A Light on Continuous Disinfection and more.